A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Drug Interaction Potential of Napabucasin in Healthy Volunteers

NCT03411122 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug-drug Interactions

Interventions

DRUG: napabucasin
DRUG: cytochrome P450 (CYP450) probe drugs or BCRP transporter substrate

Sponsor

Sumitomo Pharma America, Inc.